Live Breaking News & Updates on Opaleye Management

Stay updated with breaking news from Opaleye management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 6.7%

NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report)’s share price rose 6.7% during trading on Tuesday . The company traded as high as $21.78 and last traded at $21.58. Approximately 22,961 shares changed hands during trading, a decline of 90% from the average daily volume of 240,353 shares. The stock had previously closed at $20.23. Analyst […] ....

Canada , Jamesn-topper , Piper-sandler , Newamsterdam-pharma , Louisg-lange , Newamsterdam-pharma-company , Wolverine-asset-management , Newamsterdam-pharma-company-profile , Securities-exchange-commission , Opaleye-management-inc , Royal-bank , Schonfeld-strategic-advisors

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […] ....

Craig-hallum , Institutional-trading-of-harrow-health , Eton-pharmaceuticals-inc , Harrow-health , Envestnet-asset-management-inc , Surface-ophthalmics-inc , Securities-exchange-commission , Nasdaq , Wasatch-advisors-inc , Opaleye-management-inc , Harrow-health-inc , Prelude-capital-management

Codexis, Inc. (NASDAQ:CDXS) Receives $6.80 Consensus Target Price from Analysts

Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among […] ....

Codexis-inc , Vanguard-group-inc , Opaleye-management-inc , Nasdaq , Nantahala-capital-management , Blackrock-inc , Get-free-report , Capital-management , Opaleye-management , Get-free , Performance-enzymes

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Markl-baum , Harrow-health-trading , Institutional-trading-of-harrow-health , Blackrock-inc , Vanguard-group-inc , Pharmaceuticals-inc , Harrow-health , Opaleye-management-inc , Morgan-stanley , Insider-activity-at-harrow-health , Securities-exchange-commission